FDA Import Refusal 1FX-1131396-3/10002/1 — MSD PHARMACEUTICAL PVT LTD
The FDA refused shipment 1FX-1131396-3/10002/1 from MSD PHARMACEUTICAL PVT LTD (India) on Aug 28, 2026. The refused product falls under Drugs and Biologics — SITAGLIPTIN PHOSPHATE (ANTI-DIABETIC). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- Aug 28, 2026
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 61PDA68 SITAGLIPTIN PHOSPHATE (ANTI-DIABETIC)
- Charges
- 75